ALLMedicine™ Sarcoidosis Center

Oct 23rd, 2021 - Inorganic antigens may contribute to paediatric sarcoidosis. Thirty-six patients matched with 36 healthy controls as well as a group of 21 sickle-cell disease (SCD) controls answered an environmental questionnaire. Patients' indirect exposure to i...

Oct 23rd, 2021 - A 61-year-old man presents with painless progressive weakness and was found to have myopathy both clinically and on diagnostic workup.The etiology of his myopathy is the first reported case of anti-SRP myopathy and sarcoidosis overlap syndrome. Th...

Oct 19th, 2021 - The purpose of this study is to find out if Acthar Gel is safe and effective to treat pulmonary sarcoidosis. Participants will be randomly assigned (like flipping a coin) to receive a shot under their skin of Acthar Gel or a matching placebo gel t...

Oct 15th, 2021 - A 30-year-old man was admitted to Intensive Therapy Unit (ITU) with status epilepticus secondary to severe hypoglycaemia on a background of type 1 diabetes. CT of the brain showed generalised cerebral oedema. He was successfully stepped down to a ...

Oct 14th, 2021 - Inflammatory bowel disease (IBD) is chronic inflammation of the gastrointestinal tract, although its etiology has largely been unclear. Tumor necrosis factor inhibitors (TNF-I) are effective for the treatment. Recently, biosimilars of TNF-I, such ...

Apr 16th, 2020 - Background: The diagnosis of sarcoidosis is not standardized but is based on three major criteria: a compatible clinical presentation, finding nonnecrotizing granulomatous inflammation in one or more tissue samples, and the exclusion of alternativ...

May 13th, 2019 - Arrhythmogenic cardiomyopathy (ACM) is an arrhythmogenic disorder of the myocardium not secondary to ischemic, hypertensive, or valvular heart disease. ACM incorporates a broad spectrum of genetic, systemic, infectious, and inflammatory disorders....

Jun 9th, 2015 - Inflammatory diseases of the aorta include routine atherosclerosis, aortitis, periaortitis, and atherosclerosis with excessive inflammatory responses, such as inflammatory atherosclerotic aneurysms. The nomenclature and histologic features of thes...

Oct 19th, 2021 - The purpose of this study is to find out if Acthar Gel is safe and effective to treat pulmonary sarcoidosis. Participants will be randomly assigned (like flipping a coin) to receive a shot under their skin of Acthar Gel or a matching placebo gel t...

Oct 12th, 2021 - Airway obstruction is classified into two broad categories based on the underlying etiology: malignant and non-malignant processes. Benign central airway obstruction (BCAO), as the name suggests, is narrowing the tracheal lumen from causes unrelat...

Sep 1st, 2021 - Sarcoidosis is a multisystemic granulomatous disease of unknown cause . Sarcoidosis is chronic and progressive in 25 % of the patients. Although mediastinal lymph nodes and lung are the most frequently sites affected, extrathoracic localizations m...

Aug 24th, 2021 - Sarcoidosis is a multisystem, granulomatous disorder, most commonly affecting the lungs. Symptom burden is high, and quality of life (QoL) and social participation are negatively affected. In patients with pulmonary sarcoidosis, treatment is recom...

May 6th, 2021 - A phase 2b, open label study to assess the hemodynamic effects of increasing doses of pulsed, inhaled nitric oxide (iNO) in subjects with pulmonary hypertension associated with pulmonary fibrosis or sarcoidosis on long term oxygen therapy followed...

Sep 16th, 2021 - Nothing about sarcoidosis is easy. First identified in 1877, it is quite common. In the United States, lifetime risk is 2.4% and 0.85% for African American persons and White persons, respectively. Still, it remains an enigma. Despite study of its ...

Jul 29th, 2021 - The appearance and location of this rash are classic signs for necrobiosis lipoidica, a chronic granulomatous skin disease commonly associated with diabetes. The patient’s initial hemoglobin A1c was 12.

May 5th, 2021 - Researchers are reporting impressive results in a small, open-label trial of the JAK inhibitor tofacitinib in cutaneous sarcoidosis: 6 of 10 patients improved so much that they reached a disease activity level of zero, and all patients improved by...

Apr 28th, 2021 - This transcript has been edited for clarity. Matthew F. Watto, MD: We are back. This is The Curbsiders. I'm Dr Matthew Watto, here with my good friend, Dr Paul Williams. We're going to talk about sarcoidosis. We had a wonderful conversation with t...

Apr 19th, 2021 - Note that some links may require registration or subscription. Global coronavirus deaths passed 3 million on Saturday, due to worsening crises in Brazil, India, and France. (Associated Press) The situation is so bad in Brazil that the government i...